Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7551556

Concept 2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
2,021,000,000 JPY
-1,000,000 JPY
1,993,000,000 JPY
1,704,000,000 JPY
-27,000,000 JPY
-288,000,000 JPY
-18,000,000 JPY
1,664,000,000 JPY
1,728,000,000 JPY
-169,000,000 JPY
124,000,000 JPY
1,833,000,000 JPY
Non-operating income
Non-operating income
197,000,000 JPY
212,000,000 JPY
Non-operating expenses
Non-operating expenses
93,000,000 JPY
71,000,000 JPY
Ordinary profit (loss)
1,809,000,000 JPY
1,805,000,000 JPY
Extraordinary income
Extraordinary income
64,000,000 JPY
JPY
Profit (loss) before income taxes
1,873,000,000 JPY
1,805,000,000 JPY
Income taxes - current
346,000,000 JPY
199,000,000 JPY
Income taxes - deferred
98,000,000 JPY
283,000,000 JPY
Profit (loss)
1,428,000,000 JPY
1,323,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.